These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19185065)

  • 41. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
    Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
    Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropilin-1 is not a marker of human Foxp3+ Treg.
    Milpied P; Renand A; Bruneau J; Mendes-da-Cruz DA; Jacquelin S; Asnafi V; Rubio MT; MacIntyre E; Lepelletier Y; Hermine O
    Eur J Immunol; 2009 Jun; 39(6):1466-71. PubMed ID: 19499532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
    Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
    Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Foxp3 is required throughout the life of a regulatory T cell.
    Lopes JE; Soper DM; Ziegler SF
    Sci STKE; 2007 Jul; 2007(393):pe36. PubMed ID: 17609478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells.
    Yi H; Zhen Y; Jiang L; Zheng J; Zhao Y
    Cell Mol Immunol; 2006 Jun; 3(3):189-95. PubMed ID: 16893499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
    Wei HG; Cai B; Wang LL; Li J; Feng WH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].
    Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R
    Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.
    Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S
    Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.
    Savage ND; de Boer T; Walburg KV; Joosten SA; van Meijgaarden K; Geluk A; Ottenhoff TH
    J Immunol; 2008 Aug; 181(3):2220-6. PubMed ID: 18641362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocrine regulation of suppressor lymphocytes: role of the glucocorticoid-induced TNF-like receptor.
    Negrini S; Fenoglio D; Balestra P; Fravega M; Filaci G; Indiveri F
    Ann N Y Acad Sci; 2006 Jun; 1069():377-85. PubMed ID: 16855164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
    Banica L; Besliu A; Pistol G; Stavaru C; Ionescu R; Forsea AM; Tanaseanu C; Dumitrache S; Otelea D; Tamsulea I; Tanaseanu S; Chitonu C; Paraschiv S; Balteanu M; Stefanescu M; Matache C
    Autoimmunity; 2009 Jan; 42(1):41-9. PubMed ID: 18800250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells.
    Grindebacke H; Stenstad H; Quiding-Järbrink M; Waldenström J; Adlerberth I; Wold AE; Rudin A
    J Immunol; 2009 Oct; 183(7):4360-70. PubMed ID: 19734224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.
    Létourneau S; Krieg C; Pantaleo G; Boyman O
    J Allergy Clin Immunol; 2009 Apr; 123(4):758-62. PubMed ID: 19348914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.